Effect of Enhanced Recovery Process after Surgery for Chronic Subdural Hematoma

XIE Zefeng; CHEN Longqin; LI Shaoxi

doi:10.3969/j.issn.1672-7185.2024.01.013

Abstract：Objective To explore the effect of enhanced recovery process after surgery(ERAS)in the treatment of patients with chronic subdural hematoma(CSDH).Methods A total of 90 patients with CSDH admitted to Anxi County Hospital from January 2018 to October 2022 were selected,and all patients were treated with CSDH trepanation and drainage surgery.All the patients were randomly divided into an ERAS group treated with ERAS process and a control group treated with traditional treatment process,with 45 cases in each group.Observe and compare the hospitalization time,total cost,satisfaction,postoperative complications,anxiety and depression scores at admission,operational morning and discharge,neurological function scores at admission and 2 weeks after treatment,and daily living ability scores after 1 month of treatment between the two groups.Results The hospitalization time and total cost in the ERAS group were significantly lower than those in the control group(P<0.05).There was no significant difference in satisfaction scores between the two groups(P>0.05).The incidence of emerging lung infections and urinary tract infections in the control group was significantly higher than that in the ERAS group(P<0.05).There was no significant difference in the incidence of other postoperative complications between the two groups(P>0.05).There was no significant difference in anxiety,depression,and neurological function scores between the two groups at admission(P>0.05).The anxiety and depression scores in the ERAS group were significantly lower than those in the control group at operational morning and discharge(P<0.05).After 2 weeks of treatment,the neurological function scores of the ERAS group was significantly lower than that of the control group(P<0.05).After 1 month of treatment,the daily living ability scores of the ERAS group was significantly higher than that of the control group(P<0.05).Conclusion Patients with CSDH are treated with ERAS process,which can further reduce their hospitalization time and total costs compared to traditional treatment processes,improve their neurological function,negative emotions,and daily living abilities,and is worth promoting and using.